It is the responsibility of Bristol, North Somerset and South Gloucestershire Integrated Care Board to make available appropriate provision to meet the mental health and other care needs of the local population in Bristol.<\/p>
<\/p>
Nationally, we are supporting the expansion and transformation of mental health services for children and young people through the NHS Long Term Plan. As part of the accompanying investment of at least an extra £2.3 billion a year by March 2024, an additional 345,000 children and young people will be able to get the mental health support they need.<\/p>
<\/p>
We also provided an additional £79 million for 2021/22 to allow around 22,500 more children and young people to access community mental health services and around 2,000 more to access eating disorder services.<\/p>
<\/p>
We continue to roll out mental health support teams in schools and colleges across the country, offering early support to children experiencing anxiety, depression, and other common mental health issues. As of May 2022, eight mental health support teams were in place or planned in the area covered by the Bristol, North Somerset and South Gloucestershire integrated care system.<\/p>
NHS England has consulted on the potential to introduce five new waiting time standards as part of its clinically-led review of National Health Service access standards, including that children, young people and their families presenting to community-based mental health services should start to receive care within four weeks from referral. As a first step, NHS England has shared and promoted guidance with its local system partners to consistently report waiting times to support the development of a baseline position.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2023-04-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-04-24T15:33:27.123Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-04-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services: Bristol"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce waiting times for child and adolescent mental health services in Bristol.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"} } , "tablingMemberConstituency" : {"_value" : "Bristol West"} , "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"} ], "uin" : "181523"} , {"_about" : "http://data.parliament.uk/resources/1580055", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1580055/answer", "answerText" : {"_value" : "
The Medicines and Healthcare products Regulatory Agency (MHRA) are unable to intervene in issues relating to capacity in the EU system. However, the MHRA recognises that there is a need to increase Approved Body capacity to ensure the continued supply of imported medical devices and equipment to the UK market by reducing regulatory barriers for companies and healthcare providers importing said devices. The MHRA are engaging with, reviewing applications from and auditing a number of organisations who have applied to be designated as a UK Approved Body. The MHRA is taking a pragmatic approach to the designation of these Approved Bodies, balancing the need to establish an independent UK system against avoiding any unnecessary duplication<\/p>
On the 25th<\/sup> October 2022, the MHRA announced that there will be a 12-month extension to the implementation of new UK Medical Device Regulations to accommodate for any disruption caused by the Great Britain\u2019s departure from the European Union. Manufacturers will be able to continue to place CE marked devices on the Great Britain market after 1 July 2023. Following this, from July 2024 the transitional arrangements will apply for CE and UKCA marked devices placed on the Great Britain market. Manufacturers are also able to apply to the MHRA for an Exceptional Use Authorisation (EUA) which permits the supply of a medical device without a valid CE or UKCA mark in certain circumstances.<\/p> In addition to building Approved Body capacity and extending the implementation of the revised UK regulations, the MHRA is working, with industry partners and designated Approved Bodies, to assess what further actions can be taken to ensure ongoing supply of medical devices where manufacturers have been unable to secure ongoing certification.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2023-02-02", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-02-02T13:14:34.287Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-01-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medical Equipment: Import Controls"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce regulatory barriers for companies and healthcare providers importing medical devices and equipment from the European Union.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4433", "label" : {"_value" : "Biography information for Thangam Debbonaire"}
}
, "tablingMemberConstituency" : {"_value" : "Bristol West"}
, "tablingMemberPrinted" : [{"_value" : "Thangam Debbonaire"}
], "uin" : "131226"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}